FDA recall, , Moderate risk
Huvepharma BioCox 60 Type A Medicated Article
BioCox 60 failed to meet stability specification requirements for assay.
Summary by Recall Canary from the FDA notice
What happened
Huvepharma EAD recalled 80 bags of BioCox 60 Type A Medicated Article, Brand of Salinomycin Sodium, 60g/lb, Net wt 50 lbs (22.68) per bag, distributed by Huvepharma, Inc., Peachtree City, GA 30269, because the product failed to meet stability specification requirements for assay at the 6M and 9M timepoints. The recall, which began February 19, 2026, was added to the FDA's Enforcement Report on March 10, 2026, and classified on March 18, 2026, affecting Mississippi.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for recalled products:
- Check the brand, package size and codes such as expiration dates against the notice.
- Return it to the store where you bought it, or dispose of it properly.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
BioCox 60 Type A Medicated Article, Brand of Salinomycin Sodium
- NDC
- 23243-6807-5
- Lot code
- HSK50067
Recall details
- Company began the recall
- Sold in
- Company
- Huvepharma EAD
- Hazard
- Quality testing problem
- Risk
Moderate risk
It may cause short-term health problems in animals it is used on, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98491
- Recall number
- V-0104-2026
- Quantity recalled
- 80 bags
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA · In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
